Channel Avatar

Onkoview @UCLip0Se5exK8Vw9elUVSHRQ@youtube.com

8.1K subscribers - no pronouns :c

The videos accompany the text book ‘Molekulare Onkolologie’,


03:14
The Wnt pathway in a normal and in a tumour cell HD
02:24
The metastatic thrombus HD
01:59
Vicious cycle in the generation of osteoclastic bone metastases in mammary cancer HD
05:06
Apoptosis HD
02:11
Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia HD
03:59
Communication of tumour cells with the microenvironment HD
02:29
Effects of proteinases with metalloproteinase domains (MMPs, ADAMs) on tumour progression HD
04:43
The PI3K/AKT signalling pathway HD
05:23
Molecular action of p53 in carcinogenesis HD
05:10
The MAP-Kinase (MAPK) signalling pathway HD
03:59
Protein kinase C HD
01:30
The tumour suppressor protein PTEN HD
04:06
Oncogenic activation receptor tyrosine kinases HD
07:51
Clonal evolution of tumours HD
08:42
Antibody therapy
03:53
Hypoxia Inducible Factors (HIFs), Part 3: Effects of Hypoxia Inducible Factors (HIFs)
06:55
Hypoxia Inducible Factors (HIFs), Part 2: Regulation of HIF under normoxic and hypoxic conditions
02:26
Hypoxia Inducible Factors (HIFs), Part 1: Tumor hypoxia
05:34
NF-κB pathways, Part 3: Activation of the NF-κB pathway in malignant disease
02:55
NF-κB pathways, Part 2: Alternative NF-κB pathway
04:52
NF-κB pathways, Part 1: The canonical pathway of NF-κB activation
09:48
Notch signaling
03:39
The hedgehog signaling pathway – Part 3
03:38
The hedgehog signaling pathway – Part 2
06:24
The hedgehog signaling pathway – Part 1: Normal situation
03:44
The JAK/STAT pathway
05:31
TGF-beta signaling
04:21
Activation of mTORC1 in hamartoma syndromes and spontaneous tumors
04:50
BCR-ABL1 and the Philadelphia chromosome - Part 4: Therapy of tumors with BCR-ABL1 fusion proteins
03:00
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein
03:13
BCR-ABL1 and the Philadelphia chromosome - Part 2: The Philadelphia chromosome
02:12
BCR-ABL1 and the Philadelphia chromosome - Part 1: Normal and aberrant karyograms
01:57
The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 02
03:55
The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 01
03:47
The EGF receptor tyrosine protein kinases
05:30
General aspects of signal transduction
07:47
The cell cycle - Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors
05:20
The cell cycle, Part 1: Phases and checkpoints
04:00
Oncogenic activation receptor tyrosine kinases
03:56
Protein kinase C
05:06
The MAP-Kinase (MAPK) signalling pathway
02:00
Vicious cycle in the generation of osteoclastic bone metastases in mammary cancer
02:24
The metastatic thrombus
05:19
Molecular action of p53 in carcinogenesis
05:02
Apoptosis
03:14
The Wnt pathway in a normal and in a tumour cell
03:59
Communication of tumour cells with the microenvironment
02:29
Effects of proteinases with metalloproteinase domains (MMPs, ADAMs) on tumour progression
04:44
The PI3K/AKT signalling pathway
07:47
Clonal evolution of tumours
02:11
Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia
01:25
The tumour suppressor protein PTEN